Flu-X Anti-Viral Spray
Out of stockSOLD OUT - Join Waitlist
Why We Chose This
Birch + Fog is committed to providing you with a variety of wellness essentials for the support you need. Introducing Flu-X®, a highly effective herbal, oral, anti-viral, anti-flu and anti-cold virus spray. Confirmed to help prevent the replication of both A & B influenza viruses, Flu-X® aids your immune system in preventing the contraction of the Flu and Cold. It also reduces the severity of Flu and Cold symptoms if they are already present, and works to accelerate recovery – naturally.
Flu-X® was developed by Professor D.S. Liu, Ph.D, one of China’s most eminent and respect virologists and medical doctors, during China’s SARS epidemic in 2002/2003. Due to its highly safe and effective anti-viral properties and its success in preventing and treating SARS-CoV infected patients and and preventing SARS-CoV infections at several hospitals in China, the original drug was rebranded as Flu-X®. Over the past 5 years, this product has been sold in Canada, the US, the UK, and China.
Flu-X® is manufactured in sterile conditions at a certified GMP pharmaceuticals factory, in strict accordance with established Good Manufacturing Practices.
See Bottom of Page for further information on studies and test results
A proprietary 8:1 extract of Fructus Jujubae, Lignum Santali Albi, Rhizoma Chuanxiang, Radix Glyrrhizae, Rhioma Artractylodis, Purified Water (in each 0.5ml dosage)
What’s In the Spray Bottle
5 sprays = .5ml
40 doses per bottle
Adults, spray 5 times in the mouth, 4 times per day. Children over 6 years, spray 4 times in the mouth, 3 times per day. Use until symptoms subside. For best results, spray two of the doses in the nose.
Consult physician if symptoms persist for more than 4 days. Ask your physician if this is right for you. Keep out of reach of children and pets. Not recommended for pregnant or lactating mothers. The statements made for this product have not been evaluated by the Food and Drug Administration.
Store in cool dry place for up to 6 months.
A 160 patient placebo-controlled clinical trial of patients with Viral Respiratory Tract Infection demonstrated an 82.9% recovery rate in the Flu-X group compared to 19.6% in the placebo control group. Further, comparative in-vivo studies on mice confirm the product’s superiority to Interferon, a leading anti-viral pharmaceutical against the influenza virus, offering a protection rate of 55% compared to only 40% for Interferon. In clinical tests Flu-X has also been shown to inhibit the H.Influenza, Aureua Staphylococcus and A-hemolytic Steptococcus bacteria strains, associated with secondary flu-related, respiratory bacterial infections.
Long and short term clinical toxicology studies conducted on the product confirm Flu-X to be safe even at 400 times the recommended human dosage. Additionally, the product has been used by over 1,000 volunteers and has been shown to be safe and highly effective in the prevention and treatment of influenza, by killing and preventing the replication of the Influenza A & B Viruses.
The similarities between SARS-CoV and SARS-CoV-2 are striking, not only in name. The whole genome of SARS-CoV-2 has a 86% similarity with SARS-CoV. Both viruses share high degrees of homology to SARS-like viruses isolated in bats, suggesting that bats are the probable origin of both SARS-CoV and SARS-CoV-2. Even in terms of disease dynamics there are apparent similarities. The main transmission route is thought to be respiratory droplets, although viral shedding via faeces has also been reported for both viruses. The angiotensin-converting enzyme 2 (ACE2), found in the lower respiratory trace of humans, has been identified as the receptor used for cell entry for both SARS-CoV and SARS-CoV-2. To be clear, Flu-X is not proven to address
Professor D. S. Liu, Ph.D ~ Inventor
Professor Liu has over 40 years experience in molecular biology and virology and graduated as a physician from China’s prestigious China Medical University. He completed his post-graduate degree at the China Academy of Medical Sciences under the supervision of Professor Zhu Jiming, the scientist who isolated the first Asian influenza strain in the world, in the 1950’s. Professor Liu has worked extensively as a virologist with projects for the World Health Organization (WHO), Royal Post Graduate Medical School, U.K., Wellcome Research Laboratories, U.K., and Peninsular Laboratory Inc., in the USA. He has been awarded “National Special Contribution Scientist” by the State Council of China and is a member of the editorial committee of the “China Immunology Journal”. He is also a Scientific Advisor for the anti-cancer drug development at Swiss Debiopharm Research Foundation.
- flu friend
I started feeling the soreness in the back of my throat right when the whole world started shutting down due to the Coronavirus. With two kids at home and my wife, I was terrified that I had contracted it. Thankfully it wasn’t Covid, but I was still worried it was the flu friend suggested this product. I used as suggested, and still had symptoms before bed and in the morning, but during the day I was in top shape. A bit of fogginess and heady numbness but nothing that affected me much. I never really subdued to the symptoms of the flu, just a sneeze here and a cough there and I was perfectly fine 3 days later! I usually don’t trust “natural” products as I think most of them are snake-oil. But this works. 5-sprays, 4 times a day. Simple.